Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project
- 19 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 134, 102987
Abstract
No abstract availableKeywords
Funding Information
- French National Research Agency
- Fondation pour la Recherche Médicale
- National Agency for Research on AIDS and Viral Hepatitis
This publication has 23 references indexed in Scilit:
- Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesThe Lancet Rheumatology, 2021
- EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDsAnnals of the Rheumatic Diseases, 2021
- Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneysKidney International, 2021
- Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE)Vaccine, 2020
- Pneumococcal Polysaccharide Vaccine Ameliorates Murine LupusFrontiers in Immunology, 2019
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)Annals of the Rheumatic Diseases, 2018
- Pneumococcal infection in patients with systemic lupus erythematosusJoint Bone Spine, 2018
- Type I Interferon in the Pathogenesis of LupusThe Journal of Immunology, 2014
- Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosusArthritis Research & Therapy, 2012